162559-45-7
162559-45-7
Chemical Structure
H-Leu-Ser-Lys-Leu-OH
- CAS No.: 162559-45-7
- Formula:C21H41N5O6
- Molecular Weight:459.58
InChIKey: KEJKLBKXNJSXOW-QAETUUGQSA-N
SMILES: CC(C)C[C@@H](C(O)=O)NC([C@H](CCCCN)NC([C@H](CO)NC([C@H](CC(C)C)N)=O)=O)=O
Biological Activity: H-Leu-Ser-Lys-Leu-OH (LSYL) is a latency-associated peptide at the amino terminus of LAP, with inhibitory effect on TGF-β1 activation. H-Leu-Ser-Lys-Leu-OH, binding with KRFK (HY-P3970), can block the signal transduction of TGF-β1, and prevent the progression of hepatic damage and fibrosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
H-Leu-Ser-Lys-Leu-OH | H-Leu-Ser-Lys-Leu-OH (LSYL) is a latency-associated peptide at the amino terminus of LAP, with inhibitory effect on TGF-β1 activation. H-Leu-Ser-Lys-Leu-OH, binding with KRFK (HY-P3970), can block the signal transduction of TGF-β1, and prevent the progression of hepatic damage and fibrosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
